People with fibromyalgia may have another treatment option available soon thanks to continuing research at the Comprehensive Pain and Addiction Center.

Biomedical implants, such as breast implants and pacemakers, may be rejected as foreign bodies. Suppressing production of an immune protein could reduce this risk.

A new study found that the combination of chronic pain and anxiety or depression affects more than 12 million adults in the U.S.

Comprehensive Pain and Addiction Center researchers surveyed teens on both sides of the U.S.-Mexico border and found that strong family support can prevent children from using alcohol or drugs.

University of Arizona Health Sciences researchers will continue their study of green light therapy, a promising non-opioid pain relief option.

A study found racial and ethnic differences in the suicide prevention care provided to patients with alcohol use disorder at U.S. emergency departments.

By counting tiny molecules in a patient’s tears, Dr. Brian McKay hopes to detect vision loss early — and treat it before symptoms set in.

Researchers are filling a knowledge gap by building a powerful tool to accelerate the development of diagnostic and prognostic technologies.

Researchers are defining long COVID and exploring the underlying cause and consequences of the disease that is affecting millions of people.

University of Arizona Health Sciences researchers contributed to a National Institutes of Health-funded research effort that identified the most common long COVID symptoms with the aim of improving future diagnostics and treatment.